In Washington, officials said the White House told him after a final January vaccine action to avoid further anti-vaccine moves this year and instead pursue food policy and childhood disease treatment approvals.
Recent initiatives include an executive order expanding psychedelic research and approval of a gene therapy for children with rare hearing loss, while Trump also wants to highlight negotiated prescription drug price cuts.
The shift follows backlash over vaccine changes and staffing interventions at the health department, but Republican pollsters warn Kennedy’s anti-vaccine image could still damage candidates as Republicans fight to keep Congress.
As measles cases surge, can the administration's abrupt policy reversal effectively restore childhood vaccination rates and public trust?
Will popular new therapies overshadow the impact of deep cuts to Medicaid and the ongoing crisis in routine public health?
How Vaccine Controversies Threaten the MAHA Health Reform and GOP’s 2026 Midterm Prospects
Overview
Following Robert F. Kennedy Jr.'s endorsement of Donald Trump and his appointment as Secretary of Health and Human Services in late 2024, the MAHA movement became a central administration initiative. In 2026, MAHA was publicly rebranded to focus on chronic disease, nutrition, environmental toxins, and drug costs, promoted through a nationwide tour and celebrity endorsements. However, Kennedy's controversial vaccine policies, including firing the CDC vaccine advisory panel and altering the childhood vaccine schedule, sparked legal challenges and political backlash. This led to a strategic retreat from overt vaccine skepticism, while covert efforts to undermine vaccine infrastructure continued. The administration now balances energizing the MAHA base with appealing to broader Republican voters, facing internal tensions and electoral risks ahead of the 2026 midterms.